NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
27 hedge funds and large institutions have $392K invested in Navidea Biopharmaceuticals Inc. in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $14K
Holders
27
Holding in Top 10
–
Calls
–
Puts
$14K
Top Buyers
| 1 | +$46.6K | |
| 2 | +$35.1K | |
| 3 | +$12K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$5K |
| 5 |
ACM
Allred Capital Management
Dallas,
Texas
|
+$3.84K |
Top Sellers
| 1 | -$19K | |
| 2 | -$16K | |
| 3 | -$16K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.5K |
| 5 |
State Street
Boston,
Massachusetts
|
-$9K |